T13	Effect 218 302	fever, infectious complications, gastrointestinal tract symptoms and severe myalgias
T14	Treatment 85 97;130 158	chemotherapy cytosine arabinoside (ARA-C)
T16	Subject 201 205	five
T17	Population 201 205	five
T18	Drug 130 150	cytosine arabinoside
T19	Duration 43 54	three-month
T15	Adverse_event 206 217	experienced
E1	Adverse_event:T15